Zimmer Biomet designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products. It has a market cap of $ 22.8billion. Has a PE of 32.27, dividend yield of 0.85 per cent. Guest Nicholas Sorour, Sasfin Wealth and resident expert Paul Theron from Vestact decide whether Zimmer Biomet hot or not.